English  |  正體中文  |  简体中文  |  Items with full text/Total items : 16971/19260 (88%)
Visitors : 7637334      Online Users : 69
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version
    Please use this identifier to cite or link to this item: http://ir.cnu.edu.tw/handle/310902800/31159


    標題: 生物製劑於immune-mediated inflammatory diseases (IMIDs)之應用
    作者: Kun-Ying Li(李昆穎)
    Jia-Der Fang(方嘉德)
    貢獻者: 嘉南藥理大學藥學系
    關鍵字: immune-mediated inflammatory diseases (IMIDs)
    Immunological Agent
    Monoclonal Antibody
    日期: 2015-05-05
    上傳時間: 2018-03-27 10:24:49 (UTC+8)
    摘要: 免疫性的發炎疾病immune-mediated inflammatory diseases (IMIDs),的類型有許多,例如:(1)類風濕性關節炎(rheumatoid arthritis) 、(2)慢性發炎性之脊椎關節疾病(spondyloarthritis SpA))之僵直性脊椎關節炎(ankylosing spondylitis)、(3)乾癬及乾癬性關節炎(psoriatic arthritis)、(4)克隆氏症(Crohn's disease),與(5)潰瘍性結腸炎(ulcerative colitis)。利用生物工程上的技術製造出生物製劑,得以應用於自體免疫疾病的治療,並且在對於免疫發炎疾病的治療上有著重大的突破。而治療之藥物基本上可分為抗腫瘤壞死因子製劑(etanercept, adalimumab, golimumab等)、非抗腫瘤壞死因子製劑(abatacept,alefacept, secukinumab, ustekinumab等)和小分子口服標靶藥物(tofacitinib, apremilast等)。
    Appears in Collections:[藥學系(所)] 會議論文
    [藥理學院] 2015 第九屆嘉南藥理大學藥理學院師生研究成果發表會

    Files in This Item:

    File Description SizeFormat
    B06.pdf399KbAdobe PDF15View/Open


    All items in CNU IR are protected by copyright, with all rights reserved.


    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback